Shanghai AI Lab’s Shusheng-S2 helped resolve the 31-year-old Ghys conjecture, with a Peking University team independently ...

Recursion Pharmaceuticals announced a $10 million milestone payment from Sanofi for a new drug candidate targeting ...

Potential first-in-class dual targeting inhibitor oral small molecule to enter Sanofi’s development pipeline, with phase 1 clinical study currently planned to begin in 2027Salt Lake City, UT, Oct. 15, ...

Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Forward-Looking Statements This ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent ...

Most patients (21 of 26; 80.8%) had TRAEs of Grade 2 or lower, consistent with MEK1/2 inhibition, including dermatitis acneiform, rash, CPK increase, diarrhea, and asymptomatic LVEF decrease. Grade 3 ...

Claude Opus 6 could launch as early as next week ahead of the Anthropic IPO. Rumors suggest the new model will expand on Opus ...

Since I called it three times in the recursion, the return process also happens three times. Even though I understood it in ...

Tencent Technology's Penguin Intelligence has released its "2026 Q3 AI Trends Report," distilling industry shifts into seven core trends. The ...

Google is reportedly testing a new Gemini 4 version codenamed "Carbon" on its internal coding platform Jetski, with coding capabilities said to ...

The Relative Strength Index (RSI), a widely adopted momentum indicator in technical analysis, has recently sparked heated new ...

According to KyeGomezB, P Zero Research reports AI research taste doubled every 3 months since Dec 2025, surpassing expert baseline.